Edward Christopher Dee: Antimicrobials in serious illness and end-of-life care – lifting the veil of silence
Edward Christopher Dee, Resident Physician in Radiation Oncology at Memorial Sloan Kettering Cancer Center, shared a post on X about a recent paper he co-authored with colleagues, titled “Antimicrobials in serious illness and end-of-life care: lifting the veil of silence” published on The Lancet Infectious Diseases.
Authors: William E. Rosa, Shila Pandey, Renee Wisniewski, Craig Blinderman, Mark Wing Loong Cheong, Juan Esteban Correa-Morales, Diego Alejandro Cubides-Diaz, Sharif Folorunso, Nahla Gafer, Mohja Marhoom, Tiffanny Newman, Christian Ntizimira, Temitope Oyewole Obadare, Cihan Papan, Pedro Emilio Pérez-Cruz, Lukas Radbruch, Giri Shan Rajahram, Tomás Alejandro Reyes-Barros, Naveen Salins, Kavitha Saravu, Edward Christopher Dee.
“Talk about a truly global effort! Thank you Dr Billy Rosa, for leading our Personal View in The Lancet Group Infectious Diseases: “Antimicrobials in serious illness and end-of-life care: lifting the veil of silence.”
In this collaborative effort, we discuss:
- Widespread Use of Antimicrobials at End of Life: We highlight the elevated rates of antimicrobial use in patients with serious illnesses and at the end of life, despite limited evidence of benefit, contributing to antimicrobial resistance, a growing global health crisis.
- Global Variation in Practice and Policy Gaps: We examine antimicrobial prescribing patterns across different income-level countries, delving deep into national guidelines
- Call for Improved Stewardship and Communication: We advocate for better antimicrobial stewardship, interdisciplinary collaboration, and clearer, patient-centric communication with patients and families to align treatment with end-of-life care goals
- Global Representation: We are proud to share eight country exemplars representing the breadth of global resource settings, written by clinical, research, and policy experts who work in Chile, Colombia, Germany, India, Malaysia, Nigeria, Rwanda, and Sudan.
In addition to the clinical, psychosocial, and policy-level science presented, on a personal level, this group effort was an opportunity to be part of a deeply diverse, inclusive, multinational, and multidisciplinary team.
To “hear” the “languages” of palliative care, social work, infectious diseases, health policy, oncology, family medicine, nursing, epidemiology, psychiatry, pharmacy, microbiology, and others spoken, and to work to integrate these voices together, was a huge privilege.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023